Shypd.aiThe largest open index of AI tools
BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data using machine learning. They translate human disease biology to advance precision medicine, focusing on neurological, cardiometabolic, and rare diseases.
Trending
Also listed in
About
BioSymetrics, a Lunai Bioworks company, is a phenomics-driven drug discovery company that leverages AI and in vivo validation to identify high-confidence targets and precision medicines. They integrate massive and dynamic clinical and experimental data, including over 77 million longitudinal patient records and 1 million genomic profiles, with machine learning to make predictions. The company focuses on neurological, cardiometabolic, and rare diseases, with lead programs in common and rare epilepsies. Their approach involves connecting disease phenotype and genotype data between humans and model systems, followed by high-content in vivo validation of new targets, such as their KCC2 Epilepsy program which uses computer vision algorithms to analyze zebrafish video data.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check biosymetrics.com for current pricing.
FAQs
Trending
